252 related articles for article (PubMed ID: 34181952)
21. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children.
Said F; Haarman MG; Roofthooft MTR; Hillege HL; Ploegstra MJ; Berger RMF
J Pediatr; 2020 May; 220():139-145. PubMed ID: 32113658
[TBL] [Abstract][Full Text] [Related]
22. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
[TBL] [Abstract][Full Text] [Related]
23. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
24. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions.
Kim YM; Haghighat L; Spiekerkoetter E; Sawada H; Alvira CM; Wang L; Acharya S; Rodriguez-Colon G; Orton A; Zhao M; Rabinovitch M
Am J Pathol; 2011 Sep; 179(3):1560-72. PubMed ID: 21763677
[TBL] [Abstract][Full Text] [Related]
26. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
[TBL] [Abstract][Full Text] [Related]
27. Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension.
Simpson CE; Chen JY; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies M; Griffiths M; Vaidya RD; Brandal S; Pauciulo MW; Lutz KA; Coleman AW; Austin ED; Ivy DD; Nichols WC; Everett AD
Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32029443
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
29. Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.
Nickel NP; Lichtinghagen R; Golpon H; Olsson KM; Brand K; Welte T; Hoeper MM
Respir Res; 2013 Nov; 14(1):130. PubMed ID: 24251953
[TBL] [Abstract][Full Text] [Related]
30. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
[TBL] [Abstract][Full Text] [Related]
31. Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension.
Rafikov R; Nair V; Sinari S; Babu H; Sullivan JC; Yuan JX; Desai AA; Rafikova O
Antioxid Redox Signal; 2019 Nov; 31(13):917-932. PubMed ID: 30652485
[No Abstract] [Full Text] [Related]
32. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension.
Chouvarine P; Giera M; Kastenmüller G; Artati A; Adamski J; Bertram H; Hansmann G
Heart; 2020 Sep; 106(17):1332-1341. PubMed ID: 32079620
[TBL] [Abstract][Full Text] [Related]
33. Changes in main pulmonary artery diameter during follow-up have prognostic implications in pulmonary arterial hypertension.
Tonelli AR; Johnson S; Alkukhun L; Yadav R; Dweik RA
Respirology; 2017 Nov; 22(8):1649-1655. PubMed ID: 28514116
[TBL] [Abstract][Full Text] [Related]
34. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
[TBL] [Abstract][Full Text] [Related]
35. Elafin Treatment Rescues EGFR-Klf4 Signaling and Lung Cell Survival in Ventilated Newborn Mice.
Alejandre Alcazar MA; Kaschwich M; Ertsey R; Preuss S; Milla C; Mujahid S; Masumi J; Khan S; Mokres LM; Tian L; Mohr J; Hirani DV; Rabinovitch M; Bland RD
Am J Respir Cell Mol Biol; 2018 Nov; 59(5):623-634. PubMed ID: 29894205
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
37. Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis.
Khandagale A; Åberg M; Wikström G; Bergström Lind S; Shevchenko G; Björklund E; Siegbahn A; Christersson C
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2293-2309. PubMed ID: 32757648
[TBL] [Abstract][Full Text] [Related]
38. Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study.
Wang GF; Guan LH; Zhou DX; Chen DD; Zhang XC; Ge JB
Adv Ther; 2020 May; 37(5):2199-2209. PubMed ID: 32239458
[TBL] [Abstract][Full Text] [Related]
39. The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.
Caruso JA; Akli S; Pageon L; Hunt KK; Keyomarsi K
Oncogene; 2015 Jul; 34(27):3556-67. PubMed ID: 25195861
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
